Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksETX.L Share News (ETX)

  • There is currently no data for ETX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Shaftesbury boss invests £100,000

Fri, 04th Mar 2011 17:03

Shaftesbury chief executive Jonathan Lane has invested a further £100,000 in the property investor. Lane has bought 22,222 shares at 450p each. That takes his stake to 966,233 shares, which is worth £4.3m at the latest purchase price. Lane raised just over £99,000 from the sale of option shares last December. The property company is focused on London's theatre-land district and in February it said demand for its properties has remained healthy since the end of September. The company said investment activity in London's West End is returning to more normal levels, with Shaftesbury playing its part, having bought properties at a total cost of £30m since October. The group expects a further increase in activity over the next 12 months. Shaftesbury has tapped £486m of its £575m committed bank facilities. The average all-in cost of its bank debt at 31 January 2011 was 4.62%. Including its £61m of debenture borrowings, the overall cost of debt was 5%.Top Director Buys Shaftesbury (SHB) Director name: Mr Jonathan S LaneAmount purchased: 22,222 @ 450.00p Value: £99,999Diploma (DPLM) Director name: Mr I HendersonAmount purchased: 25,000 @ 276.00p Value: £69,000Development Securities (DSC) Director name: Mr Sarah BatesAmount purchased: 30,000 @ 203.00p Value: £60,900SThree (STHR) Director name: Mr Clayton BrendishAmount purchased: 12,000 @ 421.90p Value: £50,628CPP Group (CPP) Director name: Mr Duncan J McIntyreAmount purchased: 13,340 @ 297.00p Value: £39,620Xchanging (XCH) Director name: Mr Nigel RichAmount purchased: 50,000 @ 63.73p Value: £31,865International Ferro Metals Group (IFL) Director name: Mr Terence Vincent Coleman WillsteedAmount purchased: 100,000 @ 23.75p Value: £23,750Innovation Group (TIG) Director name: Mr Jane HallAmount purchased: 124,924 @ 15.85p Value: £19,800e-Therapeutics (ETX) Director name: Mr Steve SelfAmount purchased: 50,000 @ 36.50p Value: £18,250Mediwatch (MDW) Director name: Mr Philip G StimpsonAmount purchased: 550,000 @ 2.60p Value: £14,300Top Director Sells Serco Group (SRP) Director name: Mr Christopher R HymanAmount sold: 78,275 @ 582.76p Value: £456,155
More News
4 Jun 2015 15:22

AGM, EGM Calendar - Week Ahead

Read more
21 May 2015 08:23

e-Therapeutics Says First Patient Enrolled In Phase Ib ETS2101 Trial

Read more
31 Mar 2015 08:21

e-Therapeutics Loss Widens As It Increases Development Spending

Read more
26 Feb 2015 14:12

e-Therapeutics Believes Drug Discovery Process Producing Higher Yield

Read more
23 Jan 2015 13:36

UK DIRECTOR DEALINGS SUMMARY: Shanta Gold Non-Executive Sells Stake

Read more
21 Jan 2015 11:42

DIRECTOR DEALINGS: e-Therapeutics Finance Director Buys 150,000 Shares

Read more
16 Oct 2014 07:40

E-Therapeutics Appoints Sean Nicholson As Executive Director

Read more
16 Sep 2014 09:08

e-Therapeutics Loss Widens On Pipeline Development; Chair To Retire

Read more
9 Jul 2014 07:37

UK MORNING BRIEFING: Deutsche Bank Raises Shell View, Cuts BP

Read more
4 Jul 2014 16:30

Daily Mail General Trust's Chairman sells £15.91m-worth of shares

Viscount Rothermere, the Chairman of Daily Mail and General Trust, has traded in £15.91m-worth of shares in the multi-media and information company. Selling the stock at 860p a piece, Rothermere benefited from the rise seen in the group's share price this week, which has seen it climbed 5.56%, or

Read more
4 Jul 2014 08:59

DIRECTOR DEALINGS: e-Therapeutics Finance Chief Buys 100,000 Shares

Read more
25 Jun 2014 16:02

DIRECTOR DEALINGS: e-Therapeutics Non-Executives Allotted New Shares

Read more
12 May 2014 11:49

e-Therapeutics Loss Widens As It Continues Pipeline Development

LONDON (Alliance News) - e-Therapeutics PLC Monday posted a widened pretax loss for 2013 as it continued to invest and develop its pipeline of products. The pharmaceutical company posted a pretax loss of GBP6.1 million, widened from GBP5.0 million, as it upped its research and development e

Read more
8 May 2014 13:30

UK MIDDAY BRIEFING: Centrica Warns, Barclays Restructures

LONDON (Alliance News) - British gas parent Centrica has issued a profit warning Thursday, blaming the extreme winter weather in the US but mild conditions in the UK, as well as the intense pressure that's been put on energy providers in the UK in recent months by politicians

Read more
8 May 2014 12:23

UK WINNERS & LOSERS: Standard Chartered, Barclays Lead FTSE 100 Risers

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Thursday.
-------
FTSE 100 - WINNERS
-------
Barclays, up 4.9%. Barclays has detailed plans to shrink its investment bank with a new round

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.